Avvaa World Health Care Products Inc (AVVH)

[Enough-Already]

The now ex-CEO Jason Price was once a retail investor who was a regular contributor on this board. He became involved with the business and eventually took over as CEO and appeared to be taking this company places.

In November 2013 Jason PR'ed an alleged distribution agreement with Walgreens which stirred up quite a bit of interest in the company.
http://www.marketwatch.com/story/avvaa-world-health-care-products-announces-local-walgreens-distribution-agreement-2013-11-18

In March 2014, Jason posted consolidated financial statements showing sales increase of over 600%, along with announcing the addition of 2 new products to its Neuroskin brand, again stirring up additional interest in the company.
http://www.otcmarkets.com/stock/AVVH/filings
http://www.otcmarkets.com/stock/AVVH/news?id=78188

In May 2014 Jason Price abruptly resigned without any prior warning or indication that he may leave. No reason or explanation was ever provided for Jason's departure, and there was never any further info on the alleged Walgreens placement, and Jason never commented here at IHub ever again.
http://www.marketwatch.com/story/resignation-of-director-and-officer-2014-05-16

The general concensus at the time seemed to be that Jason stabbed everyone here in the back, and made a significant profit for himself at investor's expense, took the money and ran. Of course there were implications posted on this board by some members that the rash of positive PR's prior to his departure may have been fabricated to some extent in order to gain personal profit for Jason before he dumped however many shares he had and disappeared. If Jason continued to read this board (and I'd be very surprised if he didn't), he never posted anything to refute any accusations or explain his sudden departure or what happened to the business.

I have attempted to contact the director Dr. Mario Zamora and the company, but have never received a response, although the emails did not bounce.

I have reviewed this in consideration of legal action, but at this stage the cost of litigation would likely outweigh any compensation. Reporting this to the SEC may be an option however.

Personally I would run a mile from anything related to Jason Price, until such time as he explains to retail investors exactly what happened here. It sickens me that people can get away with this (if it is what it appears to be).

The share value is currently at $0.000001 and apparently untradable.